AOD9604 represents part of a broader scientific effort to develop targeted therapies that can isolate beneficial effects of growth hormone while avoiding unwanted systemic effects, similar to the development of selective androgen receptor modulators (SARMs) or selective estrogen receptor modulators (SERMs) in other therapeutic areas
This specific sequence was identified through systematic research aimed at isolating the lipolytic (fat-breaking) properties of growth hormone while eliminating the growth-promoting, diabetogenic, and other potentially problematic effects associated with full-length hGH therapy
This matters because many adults with low B12, whether from dietary restriction, aging, or conditions like pernicious anemia, cannot absorb enough B12 through food or oral supplements alone
Theres no crash, jitters, or dependencyjust clean, cellular-level energy and improved fat metabolism
The regional selectivity toward visceral fat has drawn particular interest given its relevance to metabolic disease research